EdgarLookup

Veris Residential, Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Veris Residential, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
26.1%
Profit Margin
Net income ÷ revenue
2.8%
Return on Assets
Net income ÷ assets
1.24x
Debt-to-Equity
Total liabilities ÷ equity
+6.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $288.43M Feb 23, 2026
FY2025 Dec 31, 2024 $271.07M Feb 23, 2026
FY2025 Dec 31, 2023 $260.30M Feb 23, 2026
FY2024 Dec 31, 2022 $213.36M Feb 24, 2025
FY2021 Dec 31, 2021 $88.23M Feb 23, 2022
FY2021 Sep 30, 2021 $83.74M Feb 23, 2022
FY2021 Jun 30, 2021 $81.25M Feb 23, 2022
FY2021 Mar 31, 2021 $76.09M Feb 23, 2022
FY2021 Dec 31, 2020 $76.56M Feb 23, 2022
FY2021 Sep 30, 2020 $79.20M Feb 23, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $75.24M Feb 23, 2026
FY2025 Dec 31, 2024 ($23.12M) Feb 23, 2026
FY2025 Dec 31, 2023 ($107.27M) Feb 23, 2026
FY2024 Dec 31, 2022 ($52.07M) Feb 24, 2025
FY2021 Dec 31, 2021 ($26.27M) Feb 23, 2022
FY2021 Sep 30, 2021 ($28.31M) Feb 23, 2022
FY2021 Jun 30, 2021 ($72.08M) Feb 23, 2022
FY2021 Mar 31, 2021 $7.62M Feb 23, 2022
FY2021 Dec 31, 2020 $65.63M Feb 23, 2022
FY2021 Sep 30, 2020 ($42.21M) Feb 23, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $105.35M Feb 21, 2018
FY2016 Dec 31, 2016 $22.11M Feb 28, 2017
FY2016 Sep 30, 2016 $27.93M Feb 28, 2017
FY2016 Jun 30, 2016 $27.37M Feb 28, 2017
FY2016 Mar 31, 2016 $27.23M Feb 28, 2017
FY2016 Dec 31, 2015 ($11.38M) Feb 28, 2017
FY2016 Sep 30, 2015 ($139.31M) Feb 28, 2017
FY2016 Jun 30, 2015 $27.35M Feb 28, 2017
FY2016 Mar 31, 2015 $27.01M Feb 28, 2017
FY2015 Dec 31, 2014 $16.55M Feb 24, 2016

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $75.97M Feb 23, 2026
FY2025 Dec 31, 2024 $52.33M Feb 23, 2026
FY2025 Dec 31, 2023 $45.54M Feb 23, 2026
FY2024 Dec 31, 2022 $66.45M Feb 24, 2025
FY2023 Dec 31, 2021 $56.12M Feb 21, 2024
FY2022 Dec 31, 2020 $85.42M Feb 22, 2023
FY2021 Dec 31, 2019 $131.84M Feb 23, 2022
FY2020 Dec 31, 2018 $167.07M Feb 25, 2021
FY2019 Dec 31, 2017 $196.14M Feb 26, 2020
FY2018 Dec 31, 2016 $100.11M Feb 20, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.71B Feb 23, 2026
FY2025 Dec 31, 2024 $2.98B Feb 23, 2026
FY2024 Dec 31, 2023 $3.24B Feb 24, 2025
FY2023 Dec 31, 2022 $3.92B Feb 21, 2024
FY2022 Dec 31, 2021 $4.53B Feb 22, 2023
FY2021 Dec 31, 2020 $5.15B Feb 23, 2022
FY2020 Dec 31, 2019 $5.29B Feb 25, 2021
FY2019 Dec 31, 2018 $5.06B Feb 26, 2020
FY2018 Dec 31, 2017 $4.96B Feb 20, 2019
FY2017 Dec 31, 2016 $4.30B Feb 21, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.43B Feb 23, 2026
FY2025 Dec 31, 2024 $1.74B Feb 23, 2026
FY2024 Dec 31, 2023 $1.94B Feb 24, 2025
FY2023 Dec 31, 2022 $2.01B Feb 21, 2024
FY2022 Dec 31, 2021 $2.56B Feb 22, 2023
FY2021 Dec 31, 2020 $3.04B Feb 23, 2022
FY2020 Dec 31, 2019 $3.09B Feb 25, 2021
FY2019 Dec 31, 2018 $3.03B Feb 26, 2020
FY2018 Dec 31, 2017 $3.08B Feb 20, 2019
FY2017 Dec 31, 2016 $2.57B Feb 21, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.15B Feb 23, 2026
FY2025 Dec 31, 2024 $1.10B Feb 23, 2026
FY2024 Dec 31, 2023 $1.14B Feb 24, 2025
FY2023 Dec 31, 2022 $1.24B Feb 21, 2024
FY2022 Dec 31, 2021 $1.28B Feb 22, 2023
FY2021 Dec 31, 2020 $1.40B Feb 23, 2022
FY2020 Dec 31, 2019 $1.49B Feb 25, 2021
FY2019 Dec 31, 2018 $1.49B Feb 26, 2020
FY2018 Dec 31, 2017 $1.48B Feb 20, 2019
FY2017 Dec 31, 2016 $1.53B Feb 21, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2021 $2.90M Feb 21, 2024
FY2021 Dec 31, 2020 $2.95M Feb 23, 2022
FY2020 Dec 31, 2019 $2.95M Feb 25, 2021
FY2019 Dec 31, 2018 $2.95M Feb 26, 2020
FY2018 Dec 31, 2017 $2.95M Feb 20, 2019
FY2017 Dec 31, 2016 $2.95M Feb 21, 2018
FY2016 Dec 31, 2015 $2.95M Feb 28, 2017
FY2015 Dec 31, 2014 $2.95M Feb 24, 2016
FY2014 Dec 31, 2013 $2.95M Feb 19, 2015
FY2013 Dec 31, 2012 $2.95M Mar 3, 2014

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($1.42B) Feb 23, 2026
FY2025 Dec 31, 2024 ($1.47B) Feb 23, 2026
FY2024 Dec 31, 2023 ($1.42B) Feb 24, 2025
FY2023 Dec 31, 2022 ($1.30B) Feb 21, 2024
FY2022 Dec 31, 2021 ($1.25B) Feb 22, 2023
FY2021 Dec 31, 2020 ($1.13B) Feb 23, 2022
FY2020 Dec 31, 2019 ($1.04B) Feb 25, 2021
FY2019 Dec 31, 2018 ($1.08B) Feb 26, 2020
FY2018 Dec 31, 2017 ($1.10B) Feb 20, 2019
FY2017 Dec 31, 2016 ($1.05B) Feb 21, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $14.13M Feb 23, 2026
FY2025 Dec 31, 2024 $7.25M Feb 23, 2026
FY2024 Dec 31, 2023 $28.01M Feb 24, 2025
FY2023 Dec 31, 2022 $26.78M Feb 21, 2024
FY2022 Dec 31, 2021 $31.75M Feb 22, 2023
FY2021 Dec 31, 2020 $38.10M Feb 23, 2022
FY2020 Dec 31, 2019 $25.59M Feb 25, 2021
FY2019 Dec 31, 2018 $29.63M Feb 26, 2020
FY2018 Dec 31, 2017 $28.18M Feb 20, 2019
FY2017 Dec 31, 2016 $31.61M Feb 21, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.36B Feb 23, 2026
FY2025 Dec 31, 2024 $1.67B Feb 23, 2026
FY2024 Dec 31, 2023 $1.85B Feb 24, 2025
FY2023 Dec 31, 2022 $1.90B Feb 21, 2024
FY2021 Dec 31, 2021 $2.39B Feb 23, 2022
FY2020 Dec 31, 2020 $2.80B Feb 25, 2021
FY2019 Dec 31, 2019 $2.81B Feb 26, 2020
FY2018 Dec 31, 2018 $2.79B Feb 20, 2019
FY2017 Dec 31, 2017 $2.81B Feb 21, 2018
FY2016 Dec 31, 2016 $2.34B Feb 28, 2017

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 23, 2026
FY2025 Dec 31, 2024 0 Feb 23, 2026
FY2025 Dec 31, 2023 (1) Feb 23, 2026
FY2024 Dec 31, 2022 0 Feb 24, 2025
FY2021 Dec 31, 2021 0 Feb 23, 2022
FY2021 Sep 30, 2021 0 Feb 23, 2022
FY2021 Jun 30, 2021 0 Feb 23, 2022
FY2021 Mar 31, 2021 0 Feb 23, 2022
FY2021 Dec 31, 2020 0 Feb 23, 2022
FY2021 Sep 30, 2020 0 Feb 23, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 23, 2026
FY2025 Dec 31, 2024 0 Feb 23, 2026
FY2025 Dec 31, 2023 (1) Feb 23, 2026
FY2024 Dec 31, 2022 0 Feb 24, 2025
FY2021 Dec 31, 2021 0 Feb 23, 2022
FY2021 Sep 30, 2021 0 Feb 23, 2022
FY2021 Jun 30, 2021 0 Feb 23, 2022
FY2021 Mar 31, 2021 0 Feb 23, 2022
FY2021 Dec 31, 2020 0 Feb 23, 2022
FY2021 Sep 30, 2020 0 Feb 23, 2022

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 93.43M Feb 23, 2026
FY2025 Dec 31, 2024 92.91M Feb 23, 2026
FY2024 Dec 31, 2023 92.23M Feb 24, 2025
FY2023 Dec 31, 2022 91.14M Feb 21, 2024
FY2022 Dec 31, 2021 90.95M Feb 22, 2023
FY2021 Dec 31, 2020 90.71M Feb 23, 2022
FY2020 Jan 3, 2020 90.60M Feb 25, 2021
FY2020 Dec 31, 2019 90.60M Feb 25, 2021
FY2019 Jan 3, 2019 90.32M Feb 26, 2020
FY2019 Dec 31, 2018 90.32M Feb 26, 2020